作者：
Campion,S. [1]
;
Aubrecht,J. [2]
;
Boekelheide,K. [3]
;
Brewster,D.W. [4]
;
Vaidya,V.S. [5]
;
Anderson,L. [6]
;
Burt,D. ;
Dere,E. ;
Hwang,K. ;
Pacheco,S. ;
Saikumar,J. ;
Schomaker,S. ;
Sigman,M. ;
Goodsaid,F.
作者单位：
Drug Safety Research and Development, Pfizer, Inc., Eastern Point Road, Groton, CT 06340, United
[1]
Strategic Regulatory Intelligence, Vertex Pharmaceuticals, Inc., 1050 K Street NW, Washington, DC
[2]
Rhode Island Hospital, Miriam Hospital, Division of Urology, Providence, RI 02903, United States
[3]
Global Head Drug Safety Evaluation, Vertex Pharmaceuticals, Inc., 130 Waverly Street, Cambridge, MA
[4]
Harvard Institutes of Medicine, Brigham and Women's Hospital, Harvard Medical School, Rm 510, 77
[5]
Brown University, Department of Pathology and Laboratory Medicine, Providence, RI 02912, United
[6]
发布时间
2014-05-27
换一批
